SSB
HQL

Sandy Spring Bank’s abrdn Life Sciences Investors HQL Stock Holding History

Sandy Spring Bank’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,099
Closed -$15.6K – 1186
2022
Q4 		$15.6K Buy
+1,099
New +$15.9K ﹤0.01% 740
2018
Q1 		– Sell
-4,018
Closed -$79K – 847
2017
Q4 		$79K Buy
+4,018
New +$80.5K 0.01% 378
2013
Q4 		– Sell
-500
Closed -$10K – 678
2013
Q3 		$10K Hold
500
– – ﹤0.01% 544
2013
Q2 		$9K Buy
+500
New +$9.03K ﹤0.01% 537

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sandy Spring Bank's HQL Position: Q1 2023 in Review

Sandy Spring Bank sold out of abrdn Life Sciences Investors (HQL) in Q1 2023, closing a stake of 1,099 shares — an estimated $15.6K sold.

Sandy Spring Bank first reported a position in HQL in Q2 2013 and held it in 4 quarters. The position peaked at $79K in Q4 2017. 78 funds tracked by Wall St. Rank hold HQL as of Q1 2023.

  • Sandy Spring Bank reported no remaining abrdn Life Sciences Investors position as of Q1 2023 after selling out during the quarter.
  • Sandy Spring Bank sold 1,099 abrdn Life Sciences Investors shares in Q1 2023, an estimated $15.6K.
  • Sandy Spring Bank first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 4 quarters.
  • Sandy Spring Bank's abrdn Life Sciences Investors position peaked at $79K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2023.

Based on Sandy Spring Bank's 13F filing for Q1 2023, filed 5 May 2023.